Recombinant allergens combined with biological markers in the diagnosis of allergic bronchopulmonary aspergillosis in cystic fibrosis patients

Clinical and Vaccine Immunology

Volumn 17, Issue 9, 2010, Pages 1330-1336

  Fricker Hidalgo, Hélène ^a   Coltey, Bérangère ^a   Llerena, Catherine ^a   Renversez, Jean Charles ^a   Grillot, Renée ^a   Pin, Isabelle ^a   Pelloux, Hervé ^a   Pinel, Claudine ^a  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; PRECIPITIN; RASPF4 ANTIGEN; RASPF6 ANTIGEN; RECOMBINANT ALLERGEN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; ARTICLE; ASPERGILLUS FUMIGATUS; BLOOD SAMPLING; BRONCHITIS; CHILD; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RHINOSINUSITIS; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SPUTUM ANALYSIS;

ADOLESCENT; ADULT; ALLERGENS; ANTIBODIES, FUNGAL; ASPERGILLOSIS, ALLERGIC BRONCHOPULMONARY; ASPERGILLUS FUMIGATUS; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INFANT; MALE; MIDDLE AGED; MYCOLOGY; PRECIPITINS; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SPUTUM; YOUNG ADULT;

EID: 77956399883     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00200-10     Document Type: Article

References (25)

1. Accurso, F. J. 2007. Update in cystic fibrosis. 2006. Am. J. Respir. Crit. Care. Med. 175:754-757.
2. Agarwal, R. 2009. Allergic bronchopulmonary aspergillosis. Chest 135:805-826.
3. Agarwal, R., D. Gupta, A. N. Aggarwal, D. Behera, and S. K. Jindal. 2006. Allergic bronchopulmonary aspergillosis. Lessons from 126 patients attending a chest clinic in North India. Chest 130:442-448.
4. Barton, R. C., R. P. Hobson, M. Denton, D. Peckham, K. Brownlee, S. Conway, and M. A. Kerr. 2008. Serologic diagnosis of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis through the detection of immunoglobulin G to Aspergillus fumigatus. Diagn. Microbiol. Infect. Dis. 62:287-291.
5. Biguet, J., P. Trav Van Ky, J. Fruit, and S. Andrieu. 1967. Identification d'une activité chymotrypsique au niveau de fractions remarquables de l'extrait antigénique d'Aspergillus fumigatus. Répercussion sur le diagnostic immunologique de l'aspergillose. Rev. Immunol. Paris 31:317-328.
6. Bowyer, P., O. Blightman, and D. W. Denning. 2006. Relative reactivity of Aspergillus allergens used in serological tests. Med. Mycol. 44:S23-S28.
7. Casaulta, C., S. Flückiger, R. Crameri, K. Blaser, and M. H. Schoeni. 2005. Time course of antibody response to recombinant Aspergillus fumigatus antigens in cystic fibrosis with and without ABPA. Pediatr. Allergy Immunol. 16:217-225.
8. Chan, C., P. C. Y. Woo, A. S. P. Leung, S. K. P. Lau, X. Y. Che, L. Coa, and K. Yuen. 2002. Detection of antibodies specific to an antigenic cell wall galactomannoprotein for serodiagnosis of Aspergillus aspergillosis. J. Clin. Microbiol. 40:2041-2045.
9. Crameri, R., M. Weichel, S. Flückiger, A. G. Glaser, and C. Rhyner. 2006. Fungal allergies: a yet unsolved problem. Chem. Immunol. Allergy 91:121-133.
10. de Oliveira, E., P. Giavina-Bianchi, L. A. M. Fonseca, A. T. França, and J. Kalil. 2007. Allergic bronchopulmonary aspergillosis diagnosis remains a challenge. Respir. Med. 101:2352-2357.
11. Knutsen, A. P., P. S. Hutcheson, R. G. Slavin, and V. P. Kurup. 2004. IgE antibody to Aspergillus fumigatus recombinant allergens in cystic fibrosis patients with allergic bronchopulmonary aspergillosis. Allergy 59:198-203.
12. Knutsen, A. P., B. Noyes, M. R. Warrier, and J. Consolino. 2005. Allergic bronchopulmonary aspergillosis in a patient with cystic fibrosis: diagnostic criteria when the IgE level is less than 500 IU/mL. Ann. Allergy Asthma Immunol. 95:488-493.
13. Kraemer, R., N. Delosea, P. Ballinari, S. Gallati, and R. Crameri. 2006. Effect of allergic bronchopulmonary aspergillosis on lung function in children with cystic fibrosis. Am. J. Respir. Crit. Care. Med. 174:1211-1220.
14. Kurup, V. P., A. P. Knutsen, R. B. Moss, and N. K. Bansal. 2006. Specific antibodies to recombinant allergens of Aspergillus fumigatus in cystic fibrosis patients with ABPA. Clin. Mol. Allergy 4:11.
15. Latzin, P., D. Harti, N. Regamey, U. Frey, M. H. Schoeni, and C. Casaulta. 2008. Comparison of serum markers for allergic bronchopulmonary aspergillosis in cystic fibrosis. Eur. Respir. J. 31:36-42.
16. Máiz, L., M. Cuevas, S. Quirce, J. F. Canon, A. Pacheco, A. Sousa, and H. Escobar. 2002. Serologic IgE immune responses against Aspergillus fumigatus and Candida albicans in patients with cystic fibrosis. Chest 121:782-788.
17. Sarfati, J., M. Monod, P. Recco, A. Sulahian, C. Pinel, E. Candolfi, T. Fontaine, J.-P. Debeaupuis, M. Tabouret, and J.-P. Latgé. 2006. Recombinant antigens as diagnostic markers for aspergillosis. Diagn. Microbiol. Infect. Dis. 55:279-291.
18. Soubani, A. O., and P. H. Chandrasekar. 2002. The clinical spectrum of pulmonary aspergillosis. Chest 121:1988-1999.
19. Stevens, D. A., R. B. Moss, V. P. Kurup, A. P. Knutsen, P. Geenberger, M. A. Judson, D. W. Denning, R. Crameri, A. S. Brody, M. Light, M. Skov, W. Malsh, G. Mastella, and participants in the Cystic Fibrosis Foundation Consensus Conference. 2003. Allergic bronchopulmonary aspergillosis in cystic fibrosis-state of the art. Cystic Fibrosis Foundation Consensus Conference. Clin. Infect. Dis. 37:225-264.
20. Takhar, P., T. P. Corrigan, L. Smurthwaite, B. J. O'Connor, S. R. Durham, T. H. Lee, and H. J. Gould. 2007. Class switch recombination to IgE in the bronchial mucosa of atopic and nonatopic patients with asthma. J. Allergy Clin. Immunol. 119:213-218.
21. Tillie-Leblond, I., and A. B. Tonnel. 2005. Allergic bronchopulmonary aspergillosis. Allergy 60:1004-1013.
22. Virnig, C., and R. K. Bush. 2007. Allergic bronchopulmonary aspergillosis: a US perspective. Curr. Opin. Pulm. Med. 13:67-71.
23. Walsh, T. J., E. J. Anaissie, D. W. Denning, R. Herbrecht, D. P. Kontoyiannis, K. A. Marr, V. A. Morrison, B. H. Segal, W. J. Steinbach, D. A. Stevens, J. A. Van Burik, J. R. Wingard, and T. F. Patterson. 2008. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin. Infect. Dis. 46:327-360.
24. Weig, M., M. Frosch, K. Tintelnot, A. Haas, U. Gross, B. Linsmeier, and J. Heesemann. 2001. Use of recombinant mitogillin for improved serodiagnosis of Aspergillus fumigatus-associated diseases. J. Clin. Microbiol. 39:1721-1730.
25. Zirbes, J. M., and C. E. Milla. 2008. Steroid-sparing effect of Omalizumab for allergic bronchopulmonary aspergillosis and cystic fibrosis. Pediatr. Pulm. 43:607-610.